Enterprise platform, queried through natural language, to help pharma, biotech, and investors make better decisions. High-quality biological patient data, enriched and integrated for use by AI agents.
NEW YORK & PARIS--(BUSINESS WIRE)--Owkin, a leading agentic AI company, has launched K Navigator, an AI-powered research co-pilot designed to revolutionize biomedical science. K Navigator is an ...
LONDON, UK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (NASDAQ: RCT) (“RedCloud” or the “Company”), the company building intelligent infrastructure for global trade, today announced its ...
PARIS, FRANCE / ACCESS Newswire / October 16, 2025 / Owkin today announces the launch of K Pro, its co-pilot bringing advanced agentic AI to biomedical research and drug development. K Pro helps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results